With the regiospecific halogenation of the complex [Ru- (bpy)2L1]+ (bpy = 2,2′-bipyridine, HL1 = 2-phenylpyridine) new organometallic starting materials are now available.
No takes yet. Share an insight, caveat, or question.
Coudret et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: